Home NDC 67296-0756 ENALAPRIL MALEATE
Product NDC 67296-0756
11-digit product format 672960756
Labeler code 67296
Product ID 67296-0756_d60ce208-dab4-e5e7-e053-2a95a90a4b4e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ENALAPRIL MALEATE
Dosage form TABLET
Route ORAL
Labeler RedPharm Drug, Inc.
Application ANDA075483
Marketing category ANDA
Marketing start 2009-12-11
Marketing end 0000-00-00
Substance ENALAPRIL MALEATE
Active strength 10 mg/1
Pharmacologic classes Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 51 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 67296-0756-1 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 67296-0756-2 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 67296-0756-1 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 67296-0756-2 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 67296-0756-1 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 67296-0756-2 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 67296-0756-1 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 67296-0756-2 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 67296-0756-1 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 67296-0756-2 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 67296-0756-1 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 67296-0756-2 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 67296-0756-1 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 67296-0756-2 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 67296-0756-1 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 67296-0756-2 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 67296-0756-1 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 67296-0756-2 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 67296-0756-1 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 67296-0756-2 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 67296-0756-1 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 67296-0756-2 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 67296-0756-1 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 67296-0756-2 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 67296-0756-1 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 67296-0756-2 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 67296-0756-1 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 67296-0756-2 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 67296-0756-1 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 67296-0756-2 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product E Excluded after deficient or non-compliant submission was not corrected fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 67296-0756-1 E Excluded after deficient or non-compliant submission was not corrected fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 67296-0756-2 E Excluded after deficient or non-compliant submission was not corrected fb8cb913e6d1…eb8c232b6be0…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 67296-0756-1 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 67296-0756-2 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A075483-001 ENALAPRIL MALEATE ENALAPRIL MALEATE 2.5MG TABLET / ORAL AB 2000-08-22 A075483-002 ENALAPRIL MALEATE ENALAPRIL MALEATE 5MG TABLET / ORAL AB 2000-08-22 A075483-003 ENALAPRIL MALEATE ENALAPRIL MALEATE 10MG TABLET / ORAL AB 2000-08-22 A075483-004 ENALAPRIL MALEATE ENALAPRIL MALEATE 20MG TABLET / ORAL AB 2000-08-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A075483-001 ENALAPRIL MALEATE 2.5MG TABLET / ORAL AB 2000-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A075483-002 ENALAPRIL MALEATE 5MG TABLET / ORAL AB 2000-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A075483-003 ENALAPRIL MALEATE 10MG TABLET / ORAL AB 2000-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A075483-004 ENALAPRIL MALEATE 20MG TABLET / ORAL AB 2000-08-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 A075483-001 ENALAPRIL MALEATE 2.5MG TABLET / ORAL AB 2000-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A075483-002 ENALAPRIL MALEATE 5MG TABLET / ORAL AB 2000-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A075483-003 ENALAPRIL MALEATE 10MG TABLET / ORAL AB 2000-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A075483-004 ENALAPRIL MALEATE 20MG TABLET / ORAL AB 2000-08-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A075483-001 ENALAPRIL MALEATE 2.5MG TABLET / ORAL AB 2000-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A075483-002 ENALAPRIL MALEATE 5MG TABLET / ORAL AB 2000-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A075483-003 ENALAPRIL MALEATE 10MG TABLET / ORAL AB 2000-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A075483-004 ENALAPRIL MALEATE 20MG TABLET / ORAL AB 2000-08-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075483-001 ENALAPRIL MALEATE 2.5MG TABLET / ORAL AB 2000-08-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075483-002 ENALAPRIL MALEATE 5MG TABLET / ORAL AB 2000-08-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075483-003 ENALAPRIL MALEATE 10MG TABLET / ORAL AB 2000-08-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075483-004 ENALAPRIL MALEATE 20MG TABLET / ORAL AB 2000-08-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A075483-001 ENALAPRIL MALEATE 2.5MG TABLET / ORAL AB 2000-08-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A075483-002 ENALAPRIL MALEATE 5MG TABLET / ORAL AB 2000-08-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A075483-003 ENALAPRIL MALEATE 10MG TABLET / ORAL AB 2000-08-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A075483-004 ENALAPRIL MALEATE 20MG TABLET / ORAL AB 2000-08-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075483-001 ENALAPRIL MALEATE 2.5MG TABLET / ORAL AB 2000-08-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075483-002 ENALAPRIL MALEATE 5MG TABLET / ORAL AB 2000-08-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075483-003 ENALAPRIL MALEATE 10MG TABLET / ORAL AB 2000-08-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075483-004 ENALAPRIL MALEATE 20MG TABLET / ORAL AB 2000-08-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075483-001 ENALAPRIL MALEATE 2.5MG TABLET / ORAL AB 2000-08-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075483-002 ENALAPRIL MALEATE 5MG TABLET / ORAL AB 2000-08-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075483-003 ENALAPRIL MALEATE 10MG TABLET / ORAL AB 2000-08-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075483-004 ENALAPRIL MALEATE 20MG TABLET / ORAL AB 2000-08-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075483-001 ENALAPRIL MALEATE 2.5MG TABLET / ORAL AB 2000-08-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075483-002 ENALAPRIL MALEATE 5MG TABLET / ORAL AB 2000-08-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075483-003 ENALAPRIL MALEATE 10MG TABLET / ORAL AB 2000-08-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075483-004 ENALAPRIL MALEATE 20MG TABLET / ORAL AB 2000-08-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075483-001 ENALAPRIL MALEATE 2.5MG TABLET / ORAL AB 2000-08-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075483-002 ENALAPRIL MALEATE 5MG TABLET / ORAL AB 2000-08-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075483-003 ENALAPRIL MALEATE 10MG TABLET / ORAL AB 2000-08-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075483-004 ENALAPRIL MALEATE 20MG TABLET / ORAL AB 2000-08-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075483-001 ENALAPRIL MALEATE 2.5MG TABLET / ORAL AB 2000-08-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075483-002 ENALAPRIL MALEATE 5MG TABLET / ORAL AB 2000-08-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075483-003 ENALAPRIL MALEATE 10MG TABLET / ORAL AB 2000-08-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075483-004 ENALAPRIL MALEATE 20MG TABLET / ORAL AB 2000-08-22 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 172 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67296-0756-1 ENALAPRIL MALEATE 30 in 1 BOTTLE TABLET 30 5 67296-0756-2 ENALAPRIL MALEATE 90 in 1 BLISTER PACK TABLET 90 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67296-0756 ENALAPRIL MALEATE TABLET [REDPHARM DRUG, INC.] 5 Legacy NDC, 2 package rows 20220121_418468ed-a7a2-53e1-e054-00144ff88e88.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 67296-0756-1 67296075601 30 TABLET in 1 BOTTLE (67296-0756-1) 30 tablet 2009-12-11 0000-00-00 No No Current 67296-0756-2 67296075602 90 TABLET in 1 BLISTER PACK (67296-0756-2) 90 tablet 2009-12-11 0000-00-00 No No Current